Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Titan Pharma (TTNP) Announces Pricing of $8 Million Underwritten Public Offering of Common Stock, Warrants
-
Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
-
Titan Pharma (TTNP) Prices 19.44M Share Registered Direct Offering at $0.14/Sh
-
Titan Pharmaceuticals Announces Pricing of $2.7 Million Registered Direct Offering
-
Maxim Group Downgrades Titan Pharmaceuticals (TTNP) to Hold, Following Earnings
-
Titan Pharma (TTNP) Announces Pricing of $2.2 Million Registered Direct Offering of Common Stock, Warrants
-
Titan Pharmaceuticals Announces Pricing of $2.2 Million Registered Direct Offering
-
Maxim Group Upgrades Titan Pharmaceuticals (TTNP) to Buy
-
Titan Pharma (TTNP) Prices 40M Unit Offering at $0.0225/Unit
-
Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering
-
Maxim Group Downgrades Titan Pharmaceuticals (TTNP) to Hold
-
Titan Pharma (TTNP) Prices $2.1 Million Registered Direct Offering of Common Stock, Warrants
-
Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering
-
Maxim Group Starts Titan Pharmaceuticals (TTNP) at Buy
-
Pre-Open Stock Movers 05/24: (MGN) (XCO) (PLCM) (GPRO) Higher; (SSW) (DSW) (SAGE) (BBY) Lower (more...)